Bluejay Diagnostics (BJDX) Change in Accured Expenses (2021 - 2026)
Bluejay Diagnostics (BJDX) posted Change in Accured Expenses of $268478.0 for Q1 2026, up 354.27% sequentially from -$105588.0 in Q4 2025, and up 143.43% YoY from $110290.0 in Q1 2025.
Bluejay Diagnostics (BJDX) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Change in Accured Expenses for 6 years, with the latest figure at $268478.0 in Q1 2026.
- Quarterly Change in Accured Expenses rose 143.43% year-over-year to $268478.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $309106.0 (up 157.23% YoY) and the FY2025 annual result came in at $150918.0, up 121.69% from the prior year.
- Change in Accured Expenses climbed to $268478.0 in Q1 2026 per BJDX's latest filing, from -$105588.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $487141.0 in Q2 2023 and troughed at -$967215.0 in Q4 2023.
- A 5-year average of $1769.6 and a median of $105223.0 in 2022 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses jumped 1213.97% in 2022, then plunged 752.48% in 2023.
- Over 5 years, Change in Accured Expenses stood at -$113459.0 in 2022, then sank by 752.48% to -$967215.0 in 2023, then surged by 90.84% to -$88561.0 in 2024, then slipped by 19.23% to -$105588.0 in 2025, then soared by 354.27% to $268478.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $268478.0, -$105588.0, and $33119.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Bluejay Diagnostics | 1.89 Mn | 1.89 Mn | - | 248,921.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 248,921.00 |
| Jun 30, 2026 | 248,921.00 |
| Mar 31, 2026 | 268,478.00 |
| Mar 31, 2026 | 268,478.00 |
| Dec 31, 2025 | -105,588.00 |
| Dec 31, 2025 | -105,588.00 |
| Sep 30, 2025 | 33,119.00 |
| Sep 30, 2025 | 33,119.00 |
| Jun 30, 2025 | 113,097.00 |
| Jun 30, 2025 | 113,097.00 |
| Mar 31, 2025 | 110,290.00 |
| Mar 31, 2025 | 110,290.00 |
| Dec 31, 2024 | -88,561.00 |
| Dec 31, 2024 | -88,561.00 |
| Sep 30, 2024 | -707,367.00 |
| Sep 30, 2024 | -707,367.00 |
| Jun 30, 2024 | 145,544.00 |
| Jun 30, 2024 | 145,544.00 |
| Mar 31, 2024 | -45,269.00 |
| Mar 31, 2024 | -45,269.00 |